Jeremy R. Messer

Jeremy R. Messer is a procurement professional specializing in research and development acquisitions within the physical, engineering, and life sciences domains. He plays a critical role in advancing agency missions by managing complex contract actions for scientific and technical services, ensuring compliance with federal acquisition regulations and fostering innovation through strategic sourcing. His work centers on soliciting and awarding contracts for applied R&D efforts, including laboratory testing, engineering analysis, and data-driven scientific studies, often requiring specialized technical expertise and rigorous performance metrics. Messer’s contracting patterns reflect a broad-based approach to vendor engagement, with no single contractor dominating his award portfolio. He cultivates relationships with a diverse array of firms—including academic research institutions, independent laboratories, and technical service providers—emphasizing competitive bidding and performance-based outcomes. His procurement strategy prioritizes technical capability and past performance over vendor size, resulting in a dynamic and fluid contractor ecosystem that adapts to evolving project requirements. His contracting activity is exclusively classified as “No Set-Aside,” indicating a deliberate focus on full and open competition without socioeconomic preferences. This approach underscores a commitment to selecting the most technically qualified offerors regardless of business size or certification status, aligning with mission-critical needs where specialized expertise outweighs socioeconomic targeting. Messer’s primary NAICS focus—541712—reveals deep specialization in R&D services across engineering, physics, chemistry, and life sciences. He routinely procures services such as experimental design, prototype development, computational modeling, and analytical testing, often requiring advanced instrumentation and subject-matter expertise. His technical domain expertise spans interdisciplinary scientific initiatives, ensuring that acquisitions support high-impact, evidence-based outcomes in federally funded research environments.